Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Irvine

Showing results (641-650 of 679) with videos related to

Pageof 68
Sort By:
Immunity|September 13, 2016
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing AntibodiesJon M Steichen, Daniel W Kulp, Talar Tokatlian, et al.
The Journal of Clinical Investigation|March 4, 2025
The saponin monophosphoryl lipid A nanoparticle adjuvant induces dose-dependent HIV vaccine responses in nonhuman primatesParham Ramezani-Rad, Ester Marina-Zárate, Laura Maiorino, et al.
Immunity|May 8, 2025
Vaccination of nonhuman primates elicits a broadly neutralizing antibody lineage targeting a quaternary epitope on the HIV-1 Env trimerFabian-Alexander Schleich, Shridhar Bale, Javier Guenaga, et al.
Nature Cancer|July 10, 2023
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancerInes Mota, Enrico Patrucco, Cristina Mastini, et al.
Immunity|December 16, 2018
Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody TitersMatthias G Pauthner, Joseph P Nkolola, Colin Havenar-Daughton, et al.
Nature|May 31, 2019
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaquesAmelia Escolano, Harry B Gristick, Morgan E Abernathy, et al.
Science Translational Medicine|August 10, 2022
Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaquesWan-Ting He, Meng Yuan, Sean Callaghan, et al.
Cell|February 12, 2022
An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicityFrancesco Borriello, Valentina Poli, Ellen Shrock, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Early clonal dominance at priming sets the trajectory for broad HIV serum neutralizationBo Liang, Yuxin Zhu, Ryan S Roark, et al.
Cell Reports|June 4, 2026
Heterologous betacoronavirus spike immunization in non-human primates elicits antibodies that neutralize both sarbeco- and merbecovirusesKatharina Dueker, Tazio Capozzola, Ziqi Feng, et al.
Pageof 68

Showing results (641-650 of 679) with videos related to

Sort By:
Pageof 68
Immunity|September 13, 2016
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing AntibodiesJon M Steichen, Daniel W Kulp, Talar Tokatlian, et al.
The Journal of Clinical Investigation|March 4, 2025
The saponin monophosphoryl lipid A nanoparticle adjuvant induces dose-dependent HIV vaccine responses in nonhuman primatesParham Ramezani-Rad, Ester Marina-Zárate, Laura Maiorino, et al.
Immunity|May 8, 2025
Vaccination of nonhuman primates elicits a broadly neutralizing antibody lineage targeting a quaternary epitope on the HIV-1 Env trimerFabian-Alexander Schleich, Shridhar Bale, Javier Guenaga, et al.
Nature Cancer|July 10, 2023
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancerInes Mota, Enrico Patrucco, Cristina Mastini, et al.
Immunity|December 16, 2018
Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody TitersMatthias G Pauthner, Joseph P Nkolola, Colin Havenar-Daughton, et al.
Nature|May 31, 2019
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaquesAmelia Escolano, Harry B Gristick, Morgan E Abernathy, et al.
Science Translational Medicine|August 10, 2022
Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaquesWan-Ting He, Meng Yuan, Sean Callaghan, et al.
Cell|February 12, 2022
An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicityFrancesco Borriello, Valentina Poli, Ellen Shrock, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Early clonal dominance at priming sets the trajectory for broad HIV serum neutralizationBo Liang, Yuxin Zhu, Ryan S Roark, et al.
Cell Reports|June 4, 2026
Heterologous betacoronavirus spike immunization in non-human primates elicits antibodies that neutralize both sarbeco- and merbecovirusesKatharina Dueker, Tazio Capozzola, Ziqi Feng, et al.
Pageof 68